← Back to search

BIORELIANCE CORPORATION

Doing business as BIORELIANCE CORP DE

ROCKVILLE, MD, 20850

UnclaimedClaim this profile (free)
Other Than Small Business

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
Centers for Disease Control and Prevention
BIORELIANCE EXPI293F—$670,262Jun 2, 2025Jul 16, 2021 – Jul 15, 2026

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Subcontracting experience

5 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Subcontractor
Department of Health and Human Services
CONDUCT QUALITY CONTROL RELEASE TESTING ON SAMPLES OF TRADITIONAL VACCINES, SPECIFICALLY FOCUSING ON THE FOLLOWING PRODUCTS: NDV MASTER SEED, NDV FINAL PRODUCT, AND NDV BULK HARVEST. PLEASE REFER TO QUOTE NUMBERS R-10151426.1, R-10151430.1, AND R-10151438.1, ATTACHED AND INCORPORATED HEREIN, FOR DETAILED SPECIFICATIONS.
0258-B056-4609
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: NY
Parent award description: BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES
View parent award on USAspending
—$726,922Jul 29, 2025— – —
Subcontractor
Department of Health and Human Services
COVID VACCINE
PO 883612, 883613
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CO
Parent award description: COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.
View parent award on USAspending
—$62,924Apr 3, 2024— – —
Subcontractor
Department of Health and Human Services
COVID VACCINE
PO 860658
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CO
Parent award description: COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.
View parent award on USAspending
—$250,618Oct 17, 2023— – —
Subcontractor
Department of Health and Human Services
COVID VACCINE
PO 832883, 832884
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CO
Parent award description: COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.
View parent award on USAspending
—$83,240Sep 21, 2023— – —
Subcontractor
Department of Health and Human Services
VACCINE DEVELOPEMENT
PO 767874, 767890
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CO
Parent award description: COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.
View parent award on USAspending
—$68,638Jan 13, 2022— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

BIORELIANCE CORPORATION – Rockville, MD | UEI H3KAG9A26K77 | FedSub